Survey Finds Many Chronic-Pain Patients Reduced Medication Use After Turning to Cannabis
Survey finds some chronic-pain patients reduced opioids after turning to cannabis, but the study cannot prove causation or safety—read the nuances.
Survey finds some chronic-pain patients reduced opioids after turning to cannabis, but the study cannot prove causation or safety—read the nuances.
A lab study suggests CBD may slow nicotine metabolism by inhibiting key enzymes, raising questions about smoking, CBD use, and quitting—human effects unknown.
Explore cannabis anatomy from roots and leaves to resin-producing trichomes, with insights into flowers, seeds, and how structure shapes growth and cannabinoids
Cannabis hangover evidence is limited and not a guarantee of impairment after eight hours; drug tests don't prove fitness for driving or duty.
Can cannabis boost sexual desire and pleasure? A large survey finds many report heightened experiences, but researchers urge caution and more rigorous studies.
How state medical-cannabis rules shape who seeks care, what conditions get recorded, and why access data isn't proof for policy decisions.
New randomized trial probes whether CBD can counteract THC's cognitive and psychotic effects in humans, challenging claims of high-CBD cannabis safety.
A large U.S. claims analysis explores whether cannabis legalization sways psychosis diagnoses and antipsychotic use, revealing nuanced, inconclusive signals.
OTC CBD products may look familiar, but safety isn’t guaranteed. Learn the risks, labeling gaps, delta-8 concerns, and when to consult a clinician.
CBGA shows potential anti-inflammatory effects in lab studies, but human evidence remains limited. What current research actually shows—and what's next.